Study to Define Safety and Effectiveness of Dolutegravir (DTG) Use in Human Immunodeficiency Virus (HIV) Positive Pregnant Women
Clinical trial NCT03564613 · UNKNOWN
Trial details
- NCT number
- NCT03564613
- Sponsor
- ViiV Healthcare
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-18
- Primary completion
- 2024-10-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.